There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Closed, Sticky:
New Resources for 1000 Genomes
|
35 responses
105,520 views
0 likes
|
by Guest
12-05-2013, 02:37 AM
|
||
|
Closed, Sticky:
Software packages for next gen sequence analysis
|
236 responses
673,719 views
1 like
|
by ECO
12-25-2009, 06:45 PM
|
||
|
3 responses
4,290 views
0 likes
|
by atcghelix
10-23-2013, 01:36 PM
|
|||
|
28 responses
9,141 views
0 likes
|
by JackieBadger
10-23-2013, 01:33 PM
|
|||
|
0 responses
1,588 views
0 likes
|
by IgorFobia
10-23-2013, 10:22 AM
|
|||
|
2 responses
1,833 views
0 likes
|
by sphil
10-23-2013, 08:10 AM
|
|||
|
1 response
2,803 views
0 likes
|
by rpauly
10-23-2013, 08:06 AM
|
|||
|
0 responses
2,354 views
0 likes
|
by meher
10-23-2013, 05:13 AM
|
|||
|
10 responses
4,627 views
0 likes
|
by frymor
10-23-2013, 04:20 AM
|
|||
|
1 response
3,283 views
0 likes
|
by GenoMax
10-23-2013, 03:38 AM
|
|||
|
5 responses
2,805 views
0 likes
|
by litali
10-23-2013, 03:19 AM
|
|||
|
10 responses
3,258 views
0 likes
|
by pony2001mx
10-22-2013, 11:34 PM
|
No topics found.
-
Single-cell studies are currently limited by expensive technologies or complex experimental workflows. Without the ability to profile...09-18-2024, 06:48 AM -
Join us for a webinar on the latest in pathogen genomics and epidemiology. Our experts will cover how NGS and machine learning can enhance understanding...08-26-2024, 09:56 AM
-
Join our upcoming webinar to explore the innovative world of RNA liquid biopsies. Learn how the advanced COMPLETE-seq technology utilizes nanopore sequencing...08-16-2024, 12:19 PM
-
-
During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.
Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...09-09-2024, 10:59 AM -
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...08-27-2024, 04:44 AM